THE LATEST Trump plows ahead with new tariffs KOSDAQ - Delayed Quote • KRW GI Innovation, Inc. (358570.KQ) Follow Compare 16,090.00 -30.00 (-0.19%) At close: 3:30:03 PM GMT+9 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations GI Innovation-LaNova Medicines Signs MOU for GI-102 + ADC Pancreatic Cancer Combination Therapy GI Innovation (KQ:358570) announced that it signed a Memorandum of Understanding (MOU) with LaNova Medicines (LaNova) for the development of GI-102 and ADC pancreatic cancer combination therapy. Performance Overview Trailing total returns as of 3/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index Return 358570.KQ KOSPI Composite Index YTD +82.22% +5.39% 1-Year +34.76% -5.44% 3-Year -15.09% -6.80%